Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2003
03/27/2003WO2002044374A3 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
03/27/2003WO2002033086A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/27/2003WO2002031141A3 Antisense oligonucleotide directed toward mammalian vegf receptor genes and uses thereof
03/27/2003WO2002029060A3 Hematopoietin receptors hpr1 and hpr2
03/27/2003WO2002026951A3 Oxidoreductases
03/27/2003WO2002024892A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
03/27/2003WO2002022684A3 Transporters and ion channels
03/27/2003WO2002016585A3 Imidazoline receptor homologs
03/27/2003WO2002016419A9 Progression suppressed gene 13 (psgen 13) and uses thereof
03/27/2003WO2002014480A9 Decellularized tissue engineered constructs and tissues
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2002005857A3 Phosphatonin-related gene and methods of use thereof
03/27/2003WO2002000692A3 Pd-l2 molecules: pd-1 ligands and uses therefor
03/27/2003WO2001083794A3 Dna transfection system for the generation of infectious influenza virus
03/27/2003WO2001062954A3 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
03/27/2003WO2001061346A3 Methods for identifying agents causing a lethal phenotype
03/27/2003US20030061638 Method for regulating cell death
03/27/2003US20030061629 Production of transgenic birds using stage X primordial germ cells
03/27/2003US20030061626 Characterisation of gene function using double stranded RNA inhibition
03/27/2003US20030061625 Modulation of PDE11A activity
03/27/2003US20030060695 Implantable artificial organ devices
03/27/2003US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders
03/27/2003US20030060616 Type II IL-1 receptors
03/27/2003US20030060614 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
03/27/2003US20030060602 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060601 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060600 Polypeptide for use in human therapeutics and diagnostics
03/27/2003US20030060444 In which an effector cell is transformed with DNA coding for chimeric receptor containing two or more cytoplasmic signalling components derived from tetraspan-transmembrane protein or antigens; anticancer agents
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030060407 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030060406 Nucleotide sequence that encodes an amino acid sequence by culturing the host cell for expression of polypeptide; agonist or antagonist
03/27/2003US20030060401 Genetic engineered drug
03/27/2003US20030060399 A heat shock protein 20 (HSP20)-derived polypeptides for treating or inhibiting smooth muscle vasospasm, smooth muscle cell proliferation, migration, and vasoconstriction
03/27/2003US20030059943 Inhibition of gene expression in preferential cell; obtain cells, infect with viral particles, recover infected cells, express viral sequences, monitor adjustment in gene expression
03/27/2003US20030059941 Transduction of bone marrow stromal cells; obtain cells, incubate with retroviral vector coding preferential enzymatic polypeptides, recover transform cell and monitor cell activity; for use as treatment of parkinson's disease
03/27/2003US20030059939 Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
03/27/2003US20030059938 Presenilin-deficient multipotent cell lines and screening methods for intramembrane-regulated proteolytic activities using these lines
03/27/2003US20030059937 Antibodies that immunospecifically bind BLyS
03/27/2003US20030059936 Method and apparatus for intracellular manipulation of a biological cell
03/27/2003US20030059935 Culture medium for in vitro culture of in vitro-produced porcine embryo and method for in vitro production of procine embryo using the culture medium
03/27/2003US20030059934 Artificial chromosomes comprising EHV sequences
03/27/2003US20030059933 Apparatus for use in the propagation of tissues
03/27/2003US20030059922 Sphingosine1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
03/27/2003US20030059916 IRAK-4: compositions and methods of use
03/27/2003US20030059909 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative disorders
03/27/2003US20030059908 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cancer and cardiovascular disorders
03/27/2003US20030059897 Immortalized cell lines and methods of making the same
03/27/2003US20030059890 Protein for use as antiinflammatory, antiproliferative and antipyretic agents
03/27/2003US20030059886 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders
03/27/2003US20030059885 Nucleotide sequences coding polypeptide for use in the treatment diagnosis and prevention of tumor and cell proliferative disorders
03/27/2003US20030059884 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059883 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059882 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059880 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059879 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059877 Human cystine knot polypeptide
03/27/2003US20030059875 Nucleotide sequences coding polypeptide for use in the treatment prevention and diagnosis of inflammatory blood and cancer disorders
03/27/2003US20030059874 Polypeptide for use in the treatment of autoimmune, inflammatatory, arthritic, atherosclerotic, allergenic, dermatitis, urticaria, adult respiratory distress syndrome, asthma, rhinitis, eczema and infections
03/27/2003US20030059871 Hematopoietin receptors HPR1 and HPR2
03/27/2003US20030059869 Novel G protein-coupled receptor, GAVE3
03/27/2003US20030059868 Retinal cell lines with extended life-span and their applications
03/27/2003US20030059859 Vertebrate protein for use in human therapeutic and diagnostics
03/27/2003US20030059852 Detecting modulators of integrin activity; obtain sample containing integrin, incubate with test compound, monitor adjustment in integrin activity, adjustment in integrin activity indicates modulator
03/27/2003US20030059845 Novel human dopamine receptor and its uses
03/27/2003US20030059835 Nucleotide sequence coding red fluorescent protein for use as diagnostic tool in genetic analysis
03/27/2003US20030059833 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059832 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059831 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and nervous system disorders
03/27/2003US20030059829 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders
03/27/2003US20030059828 Nucleotide sequences coding polypeptide for use in the treatment and preventon of tumors and skin disorders
03/27/2003US20030059812 HDAC9 polypeptides and polynucleotides and uses thereof
03/27/2003US20030059805 Nucleotide sequences coding polyeptide for use in the treatment of growth disorders in humans
03/27/2003US20030059802 Nucleotide sequences coding polypeptide for use in the prevention and treatment of infection of gut and intestine; for use aide in digestion and nutrient absorption
03/27/2003US20030059797 Animal model of and test for Alzheimer's disease
03/27/2003US20030059796 Detecting genes associated with controlling angiogenesis; obtain and culture endothelial cells, isolate ribonucleic acids, amplified or reduced concentrations of preferenial ribonucleic acids indicate association with angiogenesis
03/27/2003US20030059793 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
03/27/2003US20030059783 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059782 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases
03/27/2003US20030059780 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system and cancer diseases
03/27/2003US20030059776 bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
03/27/2003US20030059772 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/27/2003US20030059742 Osteointegration device and method
03/27/2003US20030059475 Fibrin microbeads and uses thereof
03/27/2003US20030059461 Molecular delivery vehicle for delivery of selected compounds to targets
03/27/2003US20030059437 Invention is based on identification of proteins (including agonist and antagonist antibodies) which either stimulate or inhibit immune response in mammals; immune related diseases can be treated by suppressing or enhancing immune response
03/27/2003US20030059433 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor
03/27/2003US20030059426 Method for inducing selectively suppressed immune response to transplanted tissue or cells
03/27/2003US20030059421 DNA encoding the baboon and cynomolgus macaque prostoglandin E2 receptor EP4 subtype
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003US20030059415 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/27/2003US20030059414 Cell populations which co-express CD49c and CD90
03/27/2003US20030059412 Fot treatment of disorders of bone cartilage or lung defect (such as osteoporosis and cycstic fibrosis) via transfection comprising herpes thymidine kinase gene
03/27/2003US20030059408 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/27/2003CA2709442A1 Cell populations which co-express cd49c and cd90
03/27/2003CA2484050A1 Cultured stromal cells and uses thereof
03/27/2003CA2465672A1 Cardiac transplantation of stem cells for the treatment of heart failure
03/27/2003CA2461352A1 Use of hcv core antigen assay for screening of anti-viral compounds
03/27/2003CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003CA2460985A1 Nestin-expressing hair follicle stem cells
03/27/2003CA2460812A1 Lipid-associated molecules
1 ... 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 ... 1827